Mini Review
Published on 15 Oct 2020
Manufacturing and Management of CAR T-Cell Therapy in “COVID-19’s Time”: Central Versus Point of Care Proposals
in Cancer Immunity and Immunotherapy

- 12,403 views
- 14 citations
Mini Review
Published on 15 Oct 2020
in Cancer Immunity and Immunotherapy

Original Research
Published on 15 Oct 2020
in Vaccines and Molecular Therapeutics

Original Research
Published on 15 Oct 2020
in Comparative Immunology

Mini Review
Published on 15 Oct 2020
in Alloimmunity and Transplantation

Original Research
Published on 15 Oct 2020
in Molecular Innate Immunity

Original Research
Published on 15 Oct 2020
in Autoimmune and Autoinflammatory Disorders

Review
Published on 15 Oct 2020
in Inflammation

Review
Published on 15 Oct 2020
in Immunological Tolerance and Regulation

Original Research
Published on 15 Oct 2020
in Immunological Tolerance and Regulation

Review
Published on 15 Oct 2020
in Cancer Immunity and Immunotherapy

Original Research
Published on 15 Oct 2020
in Inflammation

Review
Published on 14 Oct 2020
in Vaccines and Molecular Therapeutics

Original Research
Published on 14 Oct 2020
in Antigen Presenting Cell Biology

Review
Published on 14 Oct 2020
in Cancer Immunity and Immunotherapy

Original Research
Published on 14 Oct 2020
in Microbial Immunology

Review
Published on 14 Oct 2020
in Alloimmunity and Transplantation
